|
시장보고서
상품코드
2050711
OTC 외용 항진균제 시장 : 제품 유형별, 유효 성분별, 용도별, 사용자별, 유통 채널별, 지역별OTC Topical Antifungals Market, By Product Type, By Active Ingredient, By Application, By User, By Distribution Channel, By Geography |
||||||
OTC 외용 항진균제 시장은 2026년에 35억 달러로 추계되고 있으며, 2033년까지 52억 7,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 6.1%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 35억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 6.10% | 2033년 시장 규모 예측 : | 52억 7,000만 달러 |
세계의 OTC 외용 항진균제 시장은 진균 감염증증의 유병률 증가와 시판 의약품에 대한 수요 증가를 배경으로 최근 괄목할 만한 성장세를 보이고 있습니다. 외용 항진균제는 무좀, 백선, 칸디다증 등 다양한 진균 감염증을 치료하기 위해 피부, 손톱, 모발에 직접 바르는 약물을 말합니다. 이 시장에는 크림, 연고, 스프레이, 파우더 등 처방전 없이 쉽게 구할 수 있는 다양한 제품이 포함되어 있습니다. 이러한 제품의 편리함과 접근성은 진균 감염증으로부터 빠르고 효과적인 완화를 원하는 소비자들 사이에서 인기를 끌고 있습니다. 개인위생과 셀프케어에 대한 인식이 높아지면서 글로벌 OTC 외용 항진균제 시장은 더욱 확대될 것으로 예상되며, 이는 제조업체와 소매업체 모두에게 유망한 비즈니스 기회를 제공할 것으로 보입니다.
시장 역학
세계의 OTC 외용 항진균제 시장은 성장을 촉진하고 도전과 기회를 제공하는 몇 가지 주요 요인의 영향을 받고 있습니다. 주요 촉진요인 중 하나는 전 세계에서, 특히 열대성 기후와 위생 상태가 좋지 않은 개발도상국에서 진균 감염증증의 유병률이 증가하고 있다는 점입니다. 또한 당뇨병 유병률의 증가도 시장 성장에 기여하고 있습니다. 당뇨병은 개인이 진균 감염증에 걸리기 쉽기 때문입니다. 또한 개인 위생에 대한 인식이 높아지고 진균 감염증의 조기 치료의 중요성에 대한 인식이 높아짐에 따라 OTC 외용 항진균제에 대한 수요가 증가하고 있습니다. 그러나 처방약이나 가정요법 등 대체 치료법의 존재와 같은 제약도 있으며, 시장의 성장 가능성을 제한할 수 있습니다. 또한 일부 외용 항진균제에 따른 피부 자극, 알레르기 반응 등의 부작용이 일부 소비자의 사용을 망설이게 하는 요인으로 작용할 수 있습니다. 이러한 도전과제와 함께 시장에는 특정 소비자의 니즈와 기호에 맞는 혁신적이고 타겟팅된 제형을 개발하는 데 있으며, 제조업체에게 큰 기회가 존재합니다. 천연 및 유기농 항진균 제품에 대한 수요 증가와 신흥 시장 진출 가능성은 글로벌 OTC 외용 항진균제 시장에서 유망한 성장 기회를 보여주고 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 매출기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 이 보고서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계의 OTC 외용 항진균제 시장의 주요 기업 개요을 작성했습니다. 구체적으로는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 이 세계의 OTC 외용 항진균제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 OTC 외용 항진균제 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 OTC 외용 항진균제 시장 : 제품 유형별, 2021-2033년
제5장 세계의 OTC 외용 항진균제 시장 : 유효 성분별, 2021-2033년
제6장 세계의 OTC 외용 항진균제 시장 : 용도별, 2021-2033년
제7장 세계의 OTC 외용 항진균제 시장 : 사용자별, 2021-2033년
제8장 세계의 OTC 외용 항진균제 시장 : 유통 채널별, 2021-2033년
제9장 세계의 OTC 외용 항진균제 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
KSA 26.06.10OTC Topical Antifungals Market is estimated to be valued at USD 3.50 Bn in 2026 and is expected to reach USD 5.27 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.50 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.10% | 2033 Value Projection: | USD 5.27 Bn |
The global OTC topical antifungals market has witnessed significant growth in recent years, driven by the increasing prevalence of fungal infections and the rising demand for over-the-counter remedies. Topical antifungals are medications applied directly to the skin, nails, or hair to treat various fungal infections, such as athlete's foot, ringworm, and candidiasis. The market encompasses a wide range of products, including creams, ointments, sprays, and powders, which are readily available without a prescription. The convenience and accessibility of these products have contributed to their popularity among consumers seeking quick and effective relief from fungal infections. As awareness about personal hygiene and self-care continues to grow, the global OTC topical antifungals market is expected to expand further, offering lucrative opportunities for manufacturers and retailers alike.
Market Dynamics
The global OTC topical antifungals market is influenced by several key factors that drive its growth, pose challenges, and present opportunities. One of the primary drivers is the increasing prevalence of fungal infections worldwide, particularly in developing countries with tropical climates and poor hygiene conditions. The rising incidence of diabetes, which makes individuals more susceptible to fungal infections, also contributes to the market's growth. Additionally, the growing awareness about personal hygiene and the importance of prompt treatment for fungal infections has led to a higher demand for OTC topical antifungals. However, the market faces certain restraints, such as the availability of alternative treatment options, including prescription medications and home remedies, which may limit its growth potential. Moreover, the side effects associated with some topical antifungals, such as skin irritation and allergic reactions, may deter some consumers from using these products. Despite these challenges, the market presents significant opportunities for manufacturers to develop innovative and targeted formulations that address specific consumer needs and preferences. The increasing demand for natural and organic antifungal products, as well as the potential for expansion into emerging markets, offers promising avenues for growth in the global OTC topical antifungals market.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global OTC topical antifungals market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Johnson & Johnson, Bayer AG, GlaxoSmithKline, Pfizer Inc., Novartis AG, Merck & Co., Inc., Abbott Laboratories, Sanofi S.A., Astellas Pharma Inc., Mylan N.V., Amgen Inc., Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International, Dr. Reddy's Laboratories, and Sun Pharmaceutical Industries Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global OTC topical antifungals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global OTC topical antifungals market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Creams
- Ointments
- Sprays
- Powders
- Gels
- Lotions
- Active Ingredient Insights (Revenue, USD Bn, 2021 - 2033)
- Clotrimazole
- Miconazole
- Terbinafine
- Ketoconazole
- Tolnaftate
- Others
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Dermatophyte Infections
- Yeast Infections
- Nail Infections
- Ringworm
- Athlete's Foot
- User Insights (Revenue, USD Bn, 2021 - 2033)
- Adults
- Pediatrics
- Geriatrics
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Online Pharmacies
- Retail Pharmacies
- Supermarkets/Hypermarkets
- Specialty Stores
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Johnson & Johnson
- Bayer AG
- GlaxoSmithKline
- Pfizer Inc.
- Novartis AG
- Merck & Co., Inc.
- Abbott Laboratories
- Sanofi S.A.
- Astellas Pharma Inc.
- Mylan N.V.
- Amgen Inc.
- Teva Pharmaceutical Industries Ltd.
- Valeant Pharmaceuticals International
- Reddy's Laboratories
- Sun Pharmaceutical Industries Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global OTC Topical Antifungals Market, By Product Type
- Global OTC Topical Antifungals Market, By Active Ingredient
- Global OTC Topical Antifungals Market, By Application
- Global OTC Topical Antifungals Market, By User
- Global OTC Topical Antifungals Market, By Distribution Channel
- Global OTC Topical Antifungals Market, By Region
3. Market Dynamics, Regulations,and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global OTC Topical Antifungals Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Creams
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ointments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Sprays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Powders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Gels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Lotions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global OTC Topical Antifungals Market, By Active Ingredient, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Clotrimazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Miconazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Terbinafine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ketoconazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Tolnaftate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global OTC Topical Antifungals Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Dermatophyte Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Yeast Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Nail Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ringworm
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Athlete's Foot
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global OTC Topical Antifungals Market, By User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global OTC Topical Antifungals Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Supermarkets/Hypermarkets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Specialty Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global OTC Topical Antifungals Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Active Ingredient, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Active Ingredient, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Active Ingredient, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Active Ingredient, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Active Ingredient, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Active Ingredient, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Astellas Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Valeant Pharmaceuticals International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Reddy's Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
